A Long-Term Safety Study of ALKS 5461

Clinical trial NCT02141399 · COMPLETED

Trial details

NCT number: NCT02141399
Sponsor: Alkermes, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2014-05-01
Primary completion: 2017-11-20
Enrollment: 1485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.